Colistimethate (Par Pharmaceutical, Inc.)
Welcome to the PulseAid listing for the Colistimethate drug offered from Par Pharmaceutical, Inc.. This Polymyxin-class Antibacterial [EPC],Polymyxins [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Par Pharmaceutical, Inc. |
NON-PROPRIETARY NAME: | colistimethate sodium |
SUBSTANCE NAME: | COLISTIMETHATE SODIUM |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Polymyxin-class Antibacterial [EPC],Polymyxins [Chemical/Ingredient] |
ROUTE: | INTRAMUSCULAR; INTRAVENOUS |
DOSAGE FORM: | INJECTION |
MARKETING CATEGORY NAME: | NDA AUTHORIZED GENERIC |
START MARKETING DATE: | 2012-06-01 |
END MARKETING DATE: | 0000-00-00 |
Colistimethate HUMAN PRESCRIPTION DRUG Details:
Item Description | Colistimethate from Par Pharmaceutical, Inc. |
LABELER NAME: | Par Pharmaceutical, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 150(mg/2mL) |
START MARKETING DATE: | 2012-06-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 42023-131_8bc2cc86-e415-4960-9f43-10729ea553c3 |
PRODUCT NDC: | 42023-131 |
APPLICATION NUMBER: | NDA050108 |
Other COLISTIMETHATE SODIUM Pharmaceutical Manufacturers / Labelers: